BioLink Therapeutics
BioLink Therapeutics is a drug development company focused on accelerating the discovery of AI-powered small-molecule therapeutics targeting antimicrobial resistance (AMR) and neurodegenerative diseases. The company also licenses a patented, biomarker-driven liquid biopsy technology for rapid, point-of-care cancer screening, enabling early detection of lung, breast, colorectal, and prostate cancers with results in 15 minutes. BioLink Therapeutics differentiates itself by combining AI-driven science with affordable, accessible healthcare solutions, particularly for resource-limited regions like India. The company is preparing for clinical trials and regulatory approvals, aiming to scale its impact globally through partnerships and incubation with top biotech accelerators in India.
BioLink Therapeutics
BioLink Therapeutics is a drug development company focused on accelerating the discovery of AI-powered small-molecule therapeutics targeting antimicrobial resistance (AMR) and neurodegenerative diseases. The company also licenses a patented, biomarker-driven liquid biopsy technology for rapid, point-of-care cancer screening, enabling early detection of lung, breast, colorectal, and prostate cancers with results in 15 minutes. BioLink Therapeutics differentiates itself by combining AI-driven science with affordable, accessible healthcare solutions, particularly for resource-limited regions like India. The company is preparing for clinical trials and regulatory approvals, aiming to scale its impact globally through partnerships and incubation with top biotech accelerators in India.